Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area

Behavioural Brain Research

Volumn 217, Issue 1, 2011, Pages 41-46

  Taslimi, Zahra ^a,b   Haghparast, Abbas ^a   Hassanpour Ezatti, Majid ^b   Safari, Mir Shahram ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Cannabinoid; Carbachol; CB1 receptor; Conditioned place preference; Lateral hypothalamus; Orexin; Reward; Ventral tegmental area

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CARBACHOL; OREXIN 1 RECEPTOR;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CONDITIONING; CONTROLLED STUDY; LATERAL HYPOTHALAMUS; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SCORING SYSTEM; VENTRAL TEGMENTUM;

ANIMALS; BENZOXAZOLES; CARBACHOL; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMIC AREA, LATERAL; MALE; NEURAL PATHWAYS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTOR, CANNABINOID, CB1; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REWARD; UREA; VENTRAL TEGMENTAL AREA;

EID: 78049487489     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.10.007     Document Type: Article

References (32)

1. Aston-Jones G., Smith R.J., Moorman D.E., Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009, 56:112-121.
2. Aston-Jones G., Smith R.J., Sartor G.C., Moorman D.E., Massi L., Tahsili-Fahadasn P., et al. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res 2010, 1314:74-90.
3. Azizi P., Haghparast A., Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav Brain Res 2009, 197:119-124.
4. Carlezon W.A., Wise R.A. Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) 1996, 128:413-420.
5. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
6. Crespo I., Gomez de Heras R., Rodriguez de Fonseca F., Navarro M. Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1. Neuropharmacology 2008, 54:219-225.
7. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999, 96:748-753.
8. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
9. Ellis J., Pediani J.D., Canals M., Milasta S., Milligan G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J Biol Chem 2006, 281:38812-38824.
10. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
11. Fattore L., Cossu G., Spano M.S., Deiana S., Fadda P., Scherma M., et al. Cannabinoids and reward: interactions with the opioid system. Crit Rev Neurobiol 2004, 16:147-158.
12. Haghparast A., Azizi P., Hassanpour-Ezatti M., Khorrami H., Naderi N. Sub-chronic administration of AM251, CB1 receptor antagonist, within the nucleus accumbens induced sensitization to morphine in the rat. Neurosci Lett 2009, 467:43-47.
13. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
14. Harris G.C., Wimmer M., Randall-Thompson J.F., Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 2007, 183:43-51.
15. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
16. Hilairet S., Bouaboula M., Carriere D., Le Fur G., Casellas P. Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. J Biol Chem 2003, 278:23731-23737.
17. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology (Berl) 1983, 81:158-163.
18. Holden J.E., Naleway E. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. Brain Res 2001, 911:27-36.
19. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003, 23:7-11.
20. Malinen H., Hyytia P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcohol Clin Exp Res 2008, 32:1976-1983.
21. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
22. Mechoulam R., Ben Shabat S., Hanus L., Fride E., Vogel Z., Bayewitch M., et al. Endogenous cannabinoid ligands-chemical and biological studies. J Lipid Mediat Cell Signal 1996, 14:45-49.
23. Moaddab M., Haghparast A., Hassanpour-Ezatti M. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav Brain Res 2009, 198:466-471.
24. Morshedi M.M., Meredith G.E. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Psychopharmacology (Berl) 2008, 197:179-189.
25. Narita M., Nagumo Y., Hashimoto S., Khotib J., Miyatake M., Sakurai T., et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006, 26:398-405.
26. Narita M., Nagumo Y., Miyatake M., Ikegami D., Kurahashi K., Suzuki T. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur J Neurosci 2007, 25:1537-1545.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier Academic Press, San Diego.
28. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
29. Safari M.S., Haghparast A., Semnanian S. Effect of lidocaine administration at the nucleus locus coeruleus level on lateral hypothalamus-induced antinociception in the rat. Pharmacol Biochem Behav 2009, 92:629-634.
30. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:1. page following 696.
31. Sharf R., Sarhan M., Dileone R.J. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008, 64:175-183.
32. Zangen A., Solinas M., Ikemoto S., Goldberg S.R., Wise R.A. Two brain sites for cannabinoid reward. J Neurosci 2006, 26:4901-4907.